<DOC>
	<DOCNO>NCT02705391</DOCNO>
	<brief_summary>We intend investigate clinical application two emerge image modality technical capability currently place Mayo Clinic . The treatment Ewing Sarcoma ( ES ) , Rhabdomyosarcoma ( RMS ) soft tissue sarcoma ( STS ) patient study involve multi-disciplinary contribution nationally recognize sarcoma expert Radiation Oncology , Radiology , Orthopedic Surgery , Pediatric Oncology , Medical Oncology Pathology . Patients undergo additional magnetic resonance ( MR ) image time standard imaging . The ability compare several image modality within single cohort patient maximize potential study impact future management sarcoma patient . The collaborative nature study , essential contribution many department undoubtedly improve coordinate care sarcoma patient naturally disseminate advanced imaging experience acquire .</brief_summary>
	<brief_title>Advanced MR Imaging Sarcoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<criteria>Age ≥ 7 year . Histological confirmation newly diagnose localize newly diagnose metastatic Ewing Sarcoma , Rhabdomyosarcoma Soft tissue Sarcoma . Tumors &gt; 5 cm diameter . Planning receive RT surgery without adjuvant radiotherapy ( RT ) Mayo Clinic Rochester . Provide inform write consent ≥ 18 year . If &lt; 18 year , provide inform write assent parent legal guardian provide inform write consent . Patients must measurable disease define Section 11.0 . Willingness participate mandatory image study Mayo Clinic Rochester . Baseline MRE information deem acceptable assessment Baseline perfusion MRI deem acceptable assessment Comorbid condition would result expect survival le 5 year</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>